ClinConnect ClinConnect Logo
Search / Trial NCT06902948

Effectiveness of a Standardized Stroke Upper Limb Rehabilitation Program with Shortened Fugl-Meyer Assessment Stratification

Launched by SALLY HIU LAM WONG · Mar 24, 2025

Trial Information

Current as of July 11, 2025

Completed

Keywords

Shortened Fugl Meyer Assessment Stroke Rehabilitation Upper Limb

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • first stroke, able to attend gym training and give written consent
  • Exclusion Criteria:
  • unstable medical condition, any musculoskeletal conditions or other diseases restricted upper limb training, unfit mental state and unable to follow command

About Sally Hiu Lam Wong

Sally Hiu Lam Wong is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in biomedical sciences and extensive experience in project management, she leads initiatives that prioritize ethical standards and regulatory compliance. Her focus on innovative therapies and patient-centric approaches drives her to collaborate with diverse stakeholders, including healthcare professionals, research institutions, and regulatory agencies, ensuring the successful execution of clinical trials. Through her leadership, Sally aims to contribute to the development of groundbreaking treatments that address unmet medical needs.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported